Showing 801 - 820 results of 1,487 for search 'agent’s state', query time: 0.08s Refine Results
  1. 801
  2. 802
  3. 803
  4. 804
  5. 805

    Dobutamine-induced alterations in internal carotid artery blood flow and cerebral blood flow in healthy adults by Fengxia Yu, Dong Liu, Xia Ma, Yawen Liu, Linkun Cai, Erwei Zhao, Zixu Huang, Zhe Zhang, Tingting Zhang, PengGang Qiao, Wei Zheng, Chunyan Guo, Linxue Qian, Pengling Ren, Zhenchang Wang

    Published 2025-02-01
    “…Purpose: Dobutamine, a sympathomimetic agent, is widely used clinically, influencing cardiac output, heart rate (HR), and blood pressure (BP), which may impact cerebral blood flow (CBF), critical for brain metabolism. …”
    Get full text
    Article
  6. 806

    Toward Enteral Nutrition in the Treatment of Pediatric Crohn Disease in Canada: A Workshop to Identify Barriers and Enablers by Johan Van Limbergen, Jennifer Haskett, Anne M Griffiths, Jeff Critch, Hien Huynh, Najma Ahmed, Jennifer C deBruyn, Robert Issenman, Wael El-Matary, Thomas D Walters, Cheryl Kluthe, Marie-Eve Roy, Elizabeth Sheppard, Wallace V Crandall, Stan Cohen, Frank M Ruemmele, Arie Levine, Anthony R Otley

    Published 2015-01-01
    “…In pediatric CD, EEN is now recommended by the pediatric committee of the European Crohn’s and Colitis Organisation and the European Society for Paediatric Gastroenterology Hepatology and Nutrition as a first-choice agent to induce remission, with remission rates in pediatric studies consistently >75%. …”
    Get full text
    Article
  7. 807
  8. 808
  9. 809
  10. 810

    Particle size grouping method as a control system of efficiency flotation process on the example of coal by Kalisz D., Kuglin K., Młynarczykowska A.

    Published 2021-01-01
    “…The influence of density and size of particles with given mixing energies and parameter α on agglomeration was analysed. It was stated that the size of the particles had an effect on their agglomeration. …”
    Get full text
    Article
  11. 811

    A generic self-learning emotional framework for machines by Alberto Hernández-Marcos, Eduardo Ros

    Published 2024-10-01
    “…As a result, they often rely on case-specific solutions and arbitrary or hard-coded models that fail to generalize well to other agents and tasks. Here we propose that emotions correspond to distinct temporal patterns perceived in crucial values for living beings in their environment (like recent rewards, expected future rewards or anticipated world states) and introduce a fully self-learning emotional framework for Artificial Intelligence agents convincingly associating them with documented natural emotions. …”
    Get full text
    Article
  12. 812
  13. 813
  14. 814

    Diagnostics and treatment of gastroesophageal reflux disease: clinical guidelines of the Russian gastroenterological association by V. T. Ivashkin, I. V. Mayev, I. . A.s. Trukhmanov, Ye. K. Baranskaya, O. B. Dronova, O. V. Zayratyants, R. G. Sayfutdinov, A. A. Sheptulin, T. L. Lapina, S. S. Pirogov, Yu. A. Kucheryavy, O. A. Storonova, D. N. Andreyev

    Published 2018-08-01
    “…Nowadays PPIs are considered as the most effective and safe agents for GERD treatment. PPIs are applied for the long­term baseline treatment (no less than 4-8 wks) and maintenance therapy (6-12 months). …”
    Get full text
    Article
  15. 815
  16. 816
  17. 817
  18. 818
  19. 819

    DFT and molecular docking analyses of the effects of solvent polarity and temperature on the structural, electronic, and thermodynamic properties of p-coumaric acid: Insights for a... by Umer Sherefedin, Abebe Belay, Kusse Gudishe, Alemu Kebede, Alemayehu Getahun Kumela, Tadesse Lemma Wakjira, Dereje Gelanu, Tesfaye Feyise, Jebel Haji Mahamud, Abdulkerim Abdela, Kebede Shankute Gizew

    Published 2025-01-01
    “…Time-dependent DFT (TDDFT) analysis revealed that solvent polarity influenced UV–Vis absorption and excited-state dipole moments, leading to significant changes in electronic transitions. …”
    Get full text
    Article
  20. 820

    Alpha-adrenergic receptor agonists in terms of modern views on glaucoma monitoring and treatment by V.P. Erichev, S.Yu. Petrov, A.V. Volzhanin, D.M. Safonova, T.V. Yaremenko, S.A. Kazaryan

    Published 2019-07-01
    “…Brimonidine, a selective alpha-adrenergic receptor agonist, is the first-line treatment choice for glaucoma. This agent reduces IOP by decreasing aqueous humor production and improving uveoscleral outflow. …”
    Get full text
    Article